The spread of the pathological tau protein is central to the progression of Alzheimer’s disease (AD), and proceeds along functional neuroanatomical connections (1–6), with pathological tau burden closely correlating with cognitive decline (7–10). This evidence concerns the gene MAPT and Alzheimer disease.